Welcome to our dedicated page for Tronox Holdings Plc SEC filings (Ticker: TROX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tronox Holdings plc filings document operating results, governance matters and capital-return actions for an integrated titanium dioxide producer. Recent Form 8-K reports furnish earnings releases, selected preliminary financial results, dividend declarations, board-related disclosures and material-event exhibits.
Proxy and shareholder-vote filings cover director elections, executive compensation votes, annual meeting proposals, board committee matters and sustainability governance. The record also discloses business conditions affecting TiO2 and zircon, cost-management initiatives, mineral sands investments, restructuring charges, and industry demand, supply and manufacturing-footprint considerations.
Neuman Jeffrey N reported acquisition or exercise transactions in a Form 4 filing for TROX. The filing lists transactions totaling 63,530 shares. Following the reported transactions, holdings were 373,855 shares.
Romano John D reported acquisition or exercise transactions in a Form 4 filing for TROX. The filing lists transactions totaling 341,855 shares. Following the reported transactions, holdings were 1,575,340 shares.
Flood Jonathan reported acquisition or exercise transactions in a Form 4 filing for TROX. The filing lists transactions totaling 55,572 shares. Following the reported transactions, holdings were 70,821 shares.
Tronox Holdings plc reported that its Chief Commercial Officer, Jeffrey A. Engle, acquired 42,900 shares of common stock on February 11, 2026 through a grant priced at $0 per share. After this award, he beneficially owns 189,826 shares in total, held directly.
The grant represents restricted share units that vest in three equal annual portions on March 5, 2027, March 5, 2028, and March 5, 2029. Each vesting date requires that the participant is still providing services to the company, tying the award to ongoing employment.
Srivisal John reported acquisition or exercise transactions in a Form 4 filing for TROX. The filing lists transactions totaling 61,855 shares. Following the reported transactions, holdings were 299,138 shares.
Tronox Holdings plc announced that director Lucrece Foufopoulos-De Ridder will not seek re-election at the 2026 annual meeting when her current term ends. The company states her decision is due to other board time commitments and not any disagreement over operations, policies, or practices.
The Board also declared a quarterly cash dividend of $0.05 per share, payable on April 2, 2026, to shareholders of record at the close of business on February 23, 2026.
The Vanguard Group reported beneficial ownership of 7,707,036 shares of Tronox Holdings plc common stock, representing 4.86% of the class. Vanguard has shared voting power over 1,100,390 shares and shared dispositive power over 7,707,036 shares, with no sole voting or dispositive power.
Vanguard states that its clients, including registered investment companies and other managed accounts, have the right to receive dividends and sale proceeds from these shares, and no single other person has an interest exceeding 5% of the class. The filing also notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries are expected to report beneficial ownership separately while pursuing the same investment strategies.
Tronox Holdings plc has announced its intent to permanently close its TiO2 pigment plant in Fuzhou, China. The company disclosed this decision in conjunction with a press release that also provides selected preliminary financial results for the fourth quarter ended December 31, 2025, which is included as Exhibit 99.1. The press release is furnished, not filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
Tronox Holdings plc has announced its intent to permanently close its TiO2 pigment plant in Fuzhou, China. The company disclosed this decision in conjunction with a press release that also provides selected preliminary financial results for the fourth quarter ended December 31, 2025, which is included as Exhibit 99.1. The press release is furnished, not filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.
Tronox Holdings plc (TROX) reported Q3 2025 results showing weaker demand and restructuring impacts. Net sales were $699 million versus $804 million a year ago, with gross profit $52 million. The company posted a loss from operations of $43 million and a net loss of $100 million (basic and diluted loss per share $0.63). Year-to-date, net sales were $2.168 billion and the net loss was $296 million.
Tronox recorded $25 million of restructuring charges in Q3 and $153 million year-to-date tied to idling its Netherlands TiO2 plant; total expected charges are $165–$180 million, including $65–$75 million non-cash, with activities currently expected to complete in the first half of 2026. Operating cash flow for the nine months was $(61) million, inventories rose to $1.688 billion, and cash was $185 million. The company issued $400 million of 9.125% senior secured notes due 2030 and ended the quarter with long‑term debt, net, of $3.136 billion. Ordinary share dividends were $0.05 per share in Q3 after $0.125 per share in Q1 and Q2.
Tronox Holdings plc furnished a press release announcing its financial results for the third quarter ended September 30, 2025. The company submitted this information as an exhibit to a current report, making the earnings details available to investors through the attached release rather than directly in the body of the report.
The press release is identified as Exhibit 99.1 and is dated November 5, 2025. Tronox notes that this earnings information is being furnished, not filed, which affects how it is treated under U.S. securities laws and limits its use in certain types of legal claims and future regulatory filings unless specifically incorporated by reference.